keyword
https://read.qxmd.com/read/38635308/effectiveness-and-cost-effectiveness-of-survivorship-care-for-survivors-of-hodgkin-lymphoma-insight-study-protocol-for-a-multicenter-retrospective-cohort-study-with-a-quasi-experimental-design
#1
JOURNAL ARTICLE
Eline M J Lammers, Josée M Zijlstra, Valesca P Retèl, Berthe M P Aleman, Flora E van Leeuwen, Annelies Nijdam
BACKGROUND: Hodgkin lymphoma (HL) occurs at young ages, with the highest incidence between 20 and 40 years. While cure rates have improved to 80%-90% over the past decades, survivors of HL are at substantial risk of late treatment-related complications, such as cardiovascular diseases, breast cancer, severe infections, and hypothyroidism. To reduce morbidity and mortality from late treatment effects, the Dutch Better care after lymphoma, Evaluation of long-term Treatment Effects and screening Recommendations (BETER) consortium developed a survivorship care program for 5-year survivors of HL that includes risk-based screening for and treatment of (risk factors for) late adverse events...
April 18, 2024: JMIR Research Protocols
https://read.qxmd.com/read/38634464/antimalarial-potential-of-kerala-ayurvedic-water
#2
JOURNAL ARTICLE
Naveen Kumar Kaushik, Dinkar Sahal
BACKGROUND OBJECTIVES: The persistent threat of drug resistant malaria demands new cures. Low prevalence of malaria in the Indian state of Kerala compared with other proximal states made us explore if there is any traditional practice in Kerala which may confer protection against malaria. In this context, our attention was drawn to 'Pathimugam' i.e., Ceasalpinia sappan whose heartwood is used to prepare a red aqueous extract which is a uniquely popular drink in Kerala. METHODS: Aqueous and methanolic extracts of various organs of C...
April 12, 2024: Journal of Vector Borne Diseases
https://read.qxmd.com/read/38633851/new-treatment-options-in-chronic-hepatitis-b-how-close-are-we-to-cure
#3
REVIEW
Pınar Korkmaz, Ali Asan, Faruk Karakeçili, Süda Tekin, Neşe Demirtürk
Hepatitis B virus (HBV) infection is the leading cause of chronic liver disease worldwide. HBV-infected patients are at a lifetime risk of developing liver cirrhosis and hepatocellular carcinoma (HCC). Today, pegylated interferon (Peg-IFN) and nucleos(t)ide analogs (NAs) are used in the treatment of patients with chronic hepatitis B (CHB). Both treatment options have limitations. Despite effective viral suppression, NAs have little effect on covalently closed circular DNA (cccDNA), the stable episomal form of the HBV genome in hepatocytes...
December 2023: Infect Dis Clin Microbiol
https://read.qxmd.com/read/38632113/piperine-quercetin-and-curcumin-identified-as-promising-natural-products-for-topical-treatment-of-cutaneous-leishmaniasis
#4
JOURNAL ARTICLE
Camila M Clemente, Javier Murillo, Ariel G Garro, Natalia Arbeláez, Tatiana Pineda, Sara M Robledo, Soledad Ravetti
Leishmania braziliensis (L. braziliensis) causes cutaneous leishmaniasis (CL) in the New World. The costs and the side effects of current treatments render imperative the development of new therapies that are affordable and easy to administer. Topical treatment would be the ideal option for the treatment of CL. This underscores the urgent need for affordable and effective treatments, with natural compounds being explored as potential solutions. The alkaloid piperine (PIP), the polyphenol curcumin (CUR), and the flavonoid quercetin (QUE), known for their diverse biological properties, are promising candidates to address these parasitic diseases...
April 18, 2024: Parasitology Research
https://read.qxmd.com/read/38630965/biomaterials-based-strategies-to-enhance-angiogenesis-in-diabetic-wound-healing
#5
REVIEW
Debajyoti Pal, Pratik Das, Prasenjit Mukherjee, Subhasis Roy, Shubhamitra Chaudhuri, Shyam Sundar Kesh, Debaki Ghosh, Samit Kumar Nandi
Amidst the present healthcare issues, diabetes is unique as an emerging class of affliction with chronicity in a majority of the population. To check and control its effects, there have been huge turnover and constant development of management strategies, and though a bigger part of the health care area is involved in achieving its control and the related issues such as the effect of diabetes on wound healing and care and many of the works have reached certain successful outcomes, still there is a huge lack in managing it, with maximum effect yet to be attained...
April 17, 2024: ACS Biomaterials Science & Engineering
https://read.qxmd.com/read/38630448/neutralizing-antibodies-to-interferon-alfa-arising-during-peginterferon-therapy-of-chronic-hepatitis-b-in-children-and-adults-results-from-the-hbrn-trials
#6
JOURNAL ARTICLE
Muhammad Atif Zahoor, Joshua B Feld, Hsing-Hua Sylvia Lin, Alexander I Mosa, Loghman Salimzadeh, Robert P Perrillo, Raymond T Chung, Kathleen B Schwarz, Harry LA Janssen, Adam J Gehring, Jordan J Feld
BACKGROUND: Peginterferon-α (PegIFNα) is of limited utility during immunotolerant (IT) or immune active (IA) phases of chronic hepatitis B infection but is being explored as part of new cure regimens. Low/absent levels of IFNα found in some treated patients are associated with limited/no virological responses. AIM: To determine if sera from participants inhibit IFNα activity and/or contain therapy-induced anti-IFNα antibodies. METHODS: Pre-, on- and post-treatment sera from 61 IT trial participants on PegIFNα/ entecavir therapy and 88 IA trial participants on PegIFNα/tenofovir therapy were screened for anti-IFNα antibodies by indirect ELISA...
April 17, 2024: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/38626196/local-amphotericin-b-therapy-for-cutaneous-leishmaniasis-a-systematic-review
#7
JOURNAL ARTICLE
Líndicy Leidicy Alves, Mariana Lourenço Freire, Isadora Lana Troian, Eliane de Morais-Teixeira, Gláucia Cota
BACKGROUND: Cutaneous leishmaniasis (CL) is characterized by potentially disfiguring skin ulcers carrying significant social stigma. To mitigate systemic drug exposure and reduce the toxicity from available treatments, studies addressing new local therapeutic strategies using available medications are coming up. This review systematically compiles preclinical and clinical data on the efficacy of amphotericin B (AmB) administered locally for cutaneous leishmaniasis. METHODOLOGY: Structured searches were conducted in major databases...
April 16, 2024: PLoS Neglected Tropical Diseases
https://read.qxmd.com/read/38617740/new-direction-for-surgery-super-minimally-invasive-surgery
#8
REVIEW
En-Qiang Linghu
The top goal of modern medicine is treating disease without destroying organ structures and making patients as healthy as they were before their sickness. Minimally invasive surgery (MIS) has dominated the surgical realm because of its lesser invasiveness. However, changes in anatomical structures of the body and reconstruction of internal organs or different organs are common after traditional surgery or MIS, decreasing the quality of life of patients post-operation. Thus, I propose a new treatment mode, super MIS (SMIS), which is defined as "curing a disease or lesion which used to be treated by MIS while preserving the integrity of the organs"...
March 28, 2024: World Journal of Gastroenterology: WJG
https://read.qxmd.com/read/38616634/-chimeric-antigen-receptor-t-cells-car-t-cells-therapy-for-b-cell-hematological-malignancies-from-the-israeli-society-of-hematology-and-transfusion-medicine
#9
JOURNAL ARTICLE
Uri Greenbaum, Dana Yehudai-Ofir, Ofrat Beyar Katz, Liat Shargian, Elad Jacoby, Sigal Grisaru, Tsila Zuckerman, Ron Ram, Abraham Avigdor
Using immunotherapy to fight cancer, and specifically, the use of engineered T-cells expressing a chimeric receptor against an antigen found on malignant cells (chimeric antigen receptor, CAR-T cells) constitutes a significant breakthrough in the treatment of the disease. In recent years, several CAR-T therapies have been approved in Europe and the USA, and some are already approved and funded through the national health basket in Israel, for the indications of diffuse large B-cell lymphoma, mantle cell lymphoma and B-cell acute lymphoblastic leukemia, after the failure of at least two lines of treatment...
April 2024: Harefuah
https://read.qxmd.com/read/38615571/a-new-era-for-food-in-health-the-fda-announces-a-qualified-health-claim-for-yogurt-intake-and-type-ii-diabetes-mellitus-risk-reduction
#10
JOURNAL ARTICLE
Ronan Lordan
INTRODUCTION: Over the last two decades research has grown regarding dairy intake and health. It has been reported by many that yogurt intake may be associated with reduced risk of type 2 diabetes mellitus (T2D). In this report, the United States Food and Drug Administration (FDA) decision to announce a qualified health claim for yogurt products regarding reduced risk of T2D in response to a Danone North America petition is discussed. METHODS: Relevant literature cited in the petition along with supporting evidence from PubMed and Google Scholar databases until April 1st, 2024 were used...
April 10, 2024: Diabetes & Metabolic Syndrome
https://read.qxmd.com/read/38614981/psat1-enhances-the-efficacy-of-the-prognosis-estimation-nomogram-model-in-stage-based-clear-cell-renal-cell-carcinoma
#11
JOURNAL ARTICLE
Jun Wang, Xiaoming He, Yuanyuan Mi, Yong Q Chen, Jie Li, Rong Wang
BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is associated with a high prevalence of cancer-related deaths. The survival rates of patients are significantly lower in late-stage ccRCC than in early-stage ccRCC, due to the spread and metastasis of late-stage ccRCC, surgery has not reached the goal of radical cure, and the effect of traditional radiotherapy and chemotherapy is poor. Thus, it is crucial to accurately assess the prognosis and provide personalized treatment at an early stage in ccRCC...
April 13, 2024: BMC Cancer
https://read.qxmd.com/read/38612531/infant-acute-lymphoblastic-leukemia-new-therapeutic-opportunities
#12
REVIEW
Marika Kulczycka, Kamila Derlatka, Justyna Tasior, Maja Sygacz, Monika Lejman, Joanna Zawitkowska
Infant acute lymphoblastic leukemia (Infant ALL) is a kind of pediatric ALL, diagnosed in children under 1 year of age and accounts for less than 5% of pediatric ALL. In the infant ALL group, two subtypes can be distinguished: KMT2A -rearranged ALL, known as a more difficult to cure form and KMT2A - non-rearranged ALL with better survival outcomes. As infants with ALL have lesser treatment outcomes compared to older children, it is pivotal to provide novel treatment approaches. Progress in the development of molecularly targeted therapies and immunotherapy presents exciting opportunities for potential improvement...
March 27, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38612006/compositions-and-microstructures-of-carbonated-geopolymers-with-different-precursors
#13
JOURNAL ARTICLE
Zhuguo Li, Ko Ikeda
It is thought that geopolymers are easy to carbonate, especially when they are cured in ambient temperatures. Matrix gel's composition and microstructure, and new products of geopolymers (GPs) after carbonation were investigated in this study on the basis of XRD and SEM-EDS measurements and ternary diagram analysis, which were prepared from low-lime fly ash (FA) and ground granulated blast-furnace slag (GGBS) alone or a blend, as a precursor. The specimens were hardened in a 20 °C environment with alkali activator solution (S/N = 1...
March 25, 2024: Materials
https://read.qxmd.com/read/38611595/metabolic-fingerprint-in-childhood-acute-lymphoblastic-leukemia
#14
JOURNAL ARTICLE
Maria T Papadopoulou, Paraskevi Panagopoulou, Efstathia Paramera, Alexandros Pechlivanis, Christina Virgiliou, Eugenia Papakonstantinou, Maria Palabougiouki, Maria Ioannidou, Eleni Vasileiou, Athanasios Tragiannidis, Evangelos Papakonstantinou, Georgios Theodoridis, Emmanuel Hatzipantelis, Athanasios Evangeliou
INTRODUCTION: Acute lymphoblastic leukemia (ALL) is the most prevalent childhood malignancy. Despite high cure rates, several questions remain regarding predisposition, response to treatment, and prognosis of the disease. The role of intermediary metabolism in the individualized mechanistic pathways of the disease is unclear. We have hypothesized that children with any (sub)type of ALL have a distinct metabolomic fingerprint at diagnosis when compared: (i) to a control group; (ii) to children with a different (sub)type of ALL; (iii) to the end of the induction treatment...
March 24, 2024: Diagnostics
https://read.qxmd.com/read/38611244/evaluation-of-various-types-of-alginate-inks-for-light-mediated-extrusion-3d-printing
#15
JOURNAL ARTICLE
Aitana Zoco de la Fuente, Ane García-García, Leyre Pérez-Álvarez, Isabel Moreno-Benítez, Asier Larrea-Sebal, Cesar Martin, Jose Luis Vilas-Vilela
Naturally derived biopolymers modifying or combining with other components are excellent candidates to promote the full potential of additive manufacturing in biomedicine, cosmetics, and the food industry. This work aims to develop new photo-cross-linkable alginate-based inks for extrusion 3D printing. Specifically, this work is focused on the effect of the addition of cross-linkers with different chemical structures (polyethylene glycol diacrylate (PEGDA), N,N' -methylenebisacrylamide (NMBA), and acrylic acid (AA)) in the potential printability and physical properties of methacrylated alginate (AlgMe) hydrogels...
April 4, 2024: Polymers
https://read.qxmd.com/read/38611205/a-novel-polyfunctional-polyurethane-acrylate-derived-from-castor-oil-based-polyols-for-waterborne-uv-curable-coating-application
#16
JOURNAL ARTICLE
Youmin Tuo, Xubiao Luo, Yahong Xiong, Chang-An Xu, Teng Yuan
Because of its unique molecular structure and renewable properties, vegetable oil has gradually become the focus of researchers. In this work, castor oil was first transformed into a castor oil-based triacrylate structure (MACOG) using two steps of chemical modification, then it was prepared into castor oil-based waterborne polyurethane acrylate emulsion, and finally, a series of coating materials were prepared under UV curing. The results showed that with the increase in MACOG content, the glass transition temperature of the sample was increased from 20...
March 30, 2024: Polymers
https://read.qxmd.com/read/38611127/nonwoven-reinforced-photocurable-poly-glycerol-sebacate-based-hydrogels
#17
JOURNAL ARTICLE
Michael Phillips, Giuseppe Tronci, Christopher M Pask, Stephen J Russell
Implantable hydrogels should ideally possess mechanical properties matched to the surrounding tissues to enable adequate mechanical function while regeneration occurs. This can be challenging, especially when degradable systems with a high water content and hydrolysable chemical bonds are required in anatomical sites under constant mechanical stimulation, e.g., a foot ulcer cavity. In these circumstances, the design of hydrogel composites is a promising strategy for providing controlled structural features and macroscopic properties over time...
March 22, 2024: Polymers
https://read.qxmd.com/read/38611029/history-of-developing-acute-promyelocytic-leukemia-treatment-and-role-of-promyelocytic-leukemia-bodies
#18
REVIEW
Pierre Bercier, Hugues de Thé
The story of acute promyelocytic leukemia (APL) discovery, physiopathology, and treatment is a unique journey, transforming the most aggressive form of leukemia to the most curable. It followed an empirical route fueled by clinical breakthroughs driving major advances in biochemistry and cell biology, including the discovery of PML nuclear bodies (PML NBs) and their central role in APL physiopathology. Beyond APL, PML NBs have emerged as key players in a wide variety of biological functions, including tumor-suppression and SUMO-initiated protein degradation, underscoring their broad importance...
March 29, 2024: Cancers
https://read.qxmd.com/read/38611015/reducing-state-conflicts-between-network-motifs-synergistically-enhances-cancer-drug-effects-and-overcomes-adaptive-resistance
#19
JOURNAL ARTICLE
Yunseong Kim, Sea Rom Choi, Kwang-Hyun Cho
Inducing apoptosis in cancer cells is a primary goal in anti-cancer therapy, but curing cancer with a single drug is unattainable due to drug resistance. The complex molecular network in cancer cells causes heterogeneous responses to single-target drugs, thereby inducing an adaptive drug response. Here, we showed that targeted drug perturbations can trigger state conflicts between multi-stable motifs within a molecular regulatory network, resulting in heterogeneous drug responses. However, we revealed that properly regulating an interconnecting molecule between these motifs can synergistically minimize the heterogeneous responses and overcome drug resistance...
March 29, 2024: Cancers
https://read.qxmd.com/read/38610820/antiviral-therapy-of-chronic-hepatitis-b-virus-between-present-and-future
#20
REVIEW
Mariana Daniela Ignat, Alexia Anastasia Stefania Balta, Raisa Eloise Barbu, Miruna Luminita Draganescu, Luiza Nechita, Doina Carina Voinescu, Aurel Nechita, Ioana Anca Stefanopol, Camelia Busila, Liliana Baroiu
Background/Objectives : The objective of this study was to analyze the results of clinical trials regarding long-term antiviral therapies in chronic hepatitis with HBV to compare current therapeutic protocols and to analyze the results of preliminary studies with new antiviral therapies for HBV. Methods : Clinical studies and meta-analyses from PubMed, Google Scholar, and Research Gate from 2011 to 2024 were analyzed on patients undergoing chronic antiviral therapy for HBV, and a retrospective observational study performed in our clinic on a group of 76 patients undergoing chronic therapy with entecavir was presented...
April 2, 2024: Journal of Clinical Medicine
keyword
keyword
6772
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.